TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30688135

Group type: EXPERIMENTAL
Intervention: Pregabalin 10 mg/kg/d
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Pregabalin 2.5 mg/kg/d
Number of subjects: 295

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 295
Study: 29859628

Group type: EXPERIMENTAL
Intervention: Training box games
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Naked-eye box trainer
Number of subjects: 3

Group type: COMPARATOR
Intervention: Conventional video-based box trainer
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 3
Study: 27665522

Group type: EXPERIMENTAL
Intervention: Oritavancin
Number of subjects: 1959

Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 1959
Study: 24849794

Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation with physical training
Number of subjects: 16

Group type: COMPARATOR
Intervention: Physical training alone
Number of subjects: 16

Group type: COMPARATOR
Intervention: Transcranial direct current stimulation alone
Number of subjects: 16
Study: 22047669

Group type: EXPERIMENTAL
Intervention: Cognitive Therapy Competence Scale for Social Phobia (CTCS-SP)
Number of subjects: 98
Study: 20578869

Group type: EXPERIMENTAL
Intervention: Chin cup with 600 g of force per side (Group 1, n = 20)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Chin cup with 300 g of force per side (Group 2, n = 20)
Number of subjects: 50

Group type: COMPARATOR
Intervention: No treatment (Group 3, n = 10)
Number of subjects: 50
Study: 18635157

Group type: EXPERIMENTAL
Intervention: Brain activation during Stroop task
Number of subjects: 20
Study: 15699762

Group type: EXPERIMENTAL
Intervention: Oral ganciclovir (3 g/day, n=36)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Oral valacyclovir (8 g/day, n=35)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Deferred therapy (n=12)
Number of subjects: 83
Study: 11909906

Group type: EXPERIMENTAL
Intervention: Upper limb function training
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Lower limb function training
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group (immobilisation with an inflatable pressure splint)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Activities of daily living (ADL) scores
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Upper limb function
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Lower limb function
Number of subjects: 101
Study: 10671599

Group type: EXPERIMENTAL
Intervention: Digital radiography with a 4 million-pixel CCD
Number of subjects: 225

Group type: COMPARATOR
Intervention: Conventional radiography
Number of subjects: 225
Study: 8650274

Group type: EXPERIMENTAL
Intervention: 90-degree starting angle at a stretch speed of approximately 1.0 radian/s
Number of subjects: 5

Group type: COMPARATOR
Intervention: Various starting angles and stretch speeds
Number of subjects: 5
Study: 2005231

Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine mouthwash
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine mouthwash
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 0.1% chlorhexidine mouthwash
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: reformulated 0.1% chlorhexidine mouthwash (not commercially available)
Number of subjects: 10

Group type: COMPARATOR
Intervention: saline rinse
Number of subjects: 10
Study: 6592201

Group type: EXPERIMENTAL
Intervention: 0.243% NaF dentifrice
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.4% SnF2 dentifrice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30578888

Group type: EXPERIMENTAL
Intervention: Flocked nylon swabs
Number of subjects: 20

Group type: COMPARATOR
Intervention: Rayon swabs
Number of subjects: 20
Study: 29910030

Group type: EXPERIMENTAL
Intervention: Bempedoic acid 180 mg once daily added to ezetimibe 10 mg/day for 12 weeks
Number of subjects: 269

Group type: COMPARATOR
Intervention: Placebo added to ezetimibe 10 mg/day for 12 weeks
Number of subjects: 269
Study: 26458146

Group type: EXPERIMENTAL
Intervention: Telmisartan + Probucol
Number of subjects: 160

Group type: COMPARATOR
Intervention: Telmisartan
Number of subjects: 160
Study: 23623278

Group type: COMPARATOR
Intervention: 2-stage method (Group A)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: 4-stage method (Group B)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Skill retention assessment
Number of subjects: 117
Study: 22866693

Group type: EXPERIMENTAL
Intervention: Culturally accommodated cognitive-behavioral treatment (A-CBT)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Standard cognitive-behavioral treatment (S-CBT)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Both A-CBT and S-CBT
Number of subjects: 35
Study: 20551457

Group type: EXPERIMENTAL
Intervention: Cyanoacrylate injection
Number of subjects: 67

Group type: COMPARATOR
Intervention: Beta-blocker treatment
Number of subjects: 67
Study: 18818551

Group type: EXPERIMENTAL
Intervention: Simple auripuncture plus aspiration
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Tympanic membrane fenestration with cauterization
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Myringotomy plus grommet insertion
Number of subjects: 96
Study: 16418553

Group type: EXPERIMENTAL
Intervention: Korean traditional dance movement program (12 weeks, 3 times a week)
Number of subjects: 253
Study: 11895169

Group type: EXPERIMENTAL
Intervention: Anthropometric measures (four skinfolds)
Number of subjects: 2286

Group type: EXPERIMENTAL
Intervention: Bioelectrical impedance analysis (BIA)
Number of subjects: 2286

Group type: EXPERIMENTAL
Intervention: Bioelectrical impedance analysis (BIA) and anthropometric measures
Number of subjects: 2286
Study: 9926182

Group type: EXPERIMENTAL
Intervention: Low-flow circle anaesthesia (LFA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: High-flow circle anaesthesia (HFA)
Number of subjects: 60
Study: 8672391

Group type: EXPERIMENTAL
Intervention: Intervention group 1
Number of subjects: 1770

Group type: EXPERIMENTAL
Intervention: Intervention group 2
Number of subjects: 1770

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 1770
Study: 2221276

Group type: EXPERIMENTAL
Intervention: Mental rehearsal with imagined consequences (C)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Mental rehearsal with no imagined consequences (N)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Rest (R)
Number of subjects: 48
Study: 863552

Group type: EXPERIMENTAL
Intervention: Reinforced model
Number of subjects: 117

Group type: COMPARATOR
Intervention: Punished model
Number of subjects: 117

Group type: COMPARATOR
Intervention: Non-facilitative information
Number of subjects: 117

Group type: COMPARATOR
Intervention: Unrelated information
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Facilitative information
Number of subjects: 117
Study: 31050034

Group type: EXPERIMENTAL
Intervention: Exercise group (n=36, 3 times a week for 1 hour)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group (n=38)
Number of subjects: 74
Study: 28303530

Group type: EXPERIMENTAL
Intervention: BTH1677 (4 mg/kg, weekly) + cetuximab (initial dose 400 mg/m2, subsequent doses 250 mg/m2, weekly) + carboplatin (6 mg/mL/min AUC, Q3W) + paclitaxel (200 mg/m2, Q3W)
Number of subjects: 90

Group type: COMPARATOR
Intervention: cetuximab + carboplatin + paclitaxel (Control)
Number of subjects: 90
Study: 25601916

Group type: EXPERIMENTAL
Intervention: 3 g acetyl-l-carnitine for 12 weeks
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 72
Study: 23020996

Group type: EXPERIMENTAL
Intervention: Long GnRH agonist protocol (group I)
Number of subjects: 330

Group type: COMPARATOR
Intervention: GnRH antagonist protocol (group II)
Number of subjects: 330
Study: 20543747

Group type: EXPERIMENTAL
Intervention: CHO drink (2:1 glucose-fructose blend; 1.5 g·min)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Plain water (WAT; 675 mL·h)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Running (RUN)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Cycling (CYCLE)
Number of subjects: 8
Study: 18301402

Group type: EXPERIMENTAL
Intervention: FDG-PET
Number of subjects: 130

Group type: COMPARATOR
Intervention: Conventional (Con)
Number of subjects: 130
Study: 16749290

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI) directed to the infarct-related artery (culprit vessel)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Complete revascularization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Staged revascularization strategy
Number of subjects: 0
Study: 14657964

Group type: EXPERIMENTAL
Intervention: GP recruitment strategies including early consultation with GPs, benefits for participating GPs and patients, and a comprehensive suburb‐by‐suburb approach.
Number of subjects: 327

Group type: EXPERIMENTAL
Intervention: Referring GPs' attitudes towards participation in research.
Number of subjects: 327

Group type: COMPARATOR
Intervention: Comparison between referring and non-referring GPs.
Number of subjects: 327
Study: 10982049

Group type: EXPERIMENTAL
Intervention: Polyurethane (PU) anal plug
Number of subjects: 38

Group type: COMPARATOR
Intervention: PVA anal plug
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Both plugs
Number of subjects: 38
Study: 9250837

Group type: EXPERIMENTAL
Intervention: Dentists evaluating porcelain, direct resin composite, and indirect resin composite VRs
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Beautician students evaluating porcelain, direct resin composite, and indirect resin composite VRs
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Number of VRs made in one patient
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Discolouration of the teeth before treatment
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Type of VR
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Number of VRs
Number of subjects: 112
Study: 8039040

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of salbutamol (0.5 mg)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Nebulization of salbutamol (10 mg)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Both treatments (i.v. and nebulization)
Number of subjects: 34
Study: 2663010

Group type: EXPERIMENTAL
Intervention: Oxazepam
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Postoperative period
Number of subjects: 60
Study: 4199744

Group type: EXPERIMENTAL
Intervention: Chloramphenicol
Number of subjects: 0
Study: 31748253

Group type: EXPERIMENTAL
Intervention: Nurse home visiting
Number of subjects: 618

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 618
Study: 28974061

Group type: EXPERIMENTAL
Intervention: WNJ SJOV
Number of subjects: 1781

Group type: COMPARATOR
Intervention: WNJ oxygen
Number of subjects: 1781

Group type: COMPARATOR
Intervention: Nasal cannula oxygen
Number of subjects: 1781
Study: 26032442

Group type: EXPERIMENTAL
Intervention: lisdexamfetamine dimesylate
Number of subjects: 260

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 260
Study: 23712109

Group type: EXPERIMENTAL
Intervention: DBT-PTSD
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control (treatment-as-usual wait list)
Number of subjects: 74
Study: 21852403

Group type: EXPERIMENTAL
Intervention: Ex-Def (SIC without replacing the energy deficit)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ex-Bal (SIC with replacing the energy deficit)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 12
Study: 19587124

Group type: EXPERIMENTAL
Intervention: Responsive feeding intervention (6-session educational program)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Informational control group
Number of subjects: 203
Study: 18075400

Group type: EXPERIMENTAL
Intervention: beta-Endorphin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Naloxone 0.8 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Adenosine (various doses)
Number of subjects: 40
Study: 15483563

Group type: EXPERIMENTAL
Intervention: Paroxetine treatment
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 17
Study: 11498727

Group type: EXPERIMENTAL
Intervention: B. monniera (300 mg)
Number of subjects: 0
Study: 8761844

Group type: EXPERIMENTAL
Intervention: 20 micrograms beraprost sodium (BPS60 group)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: 40 micrograms beraprost sodium (BPS120 group)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: 60 micrograms beraprost sodium (BPS180 group)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: 60 micrograms beraprost sodium
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: 120 micrograms beraprost sodium
Number of subjects: 164
Study: 1317294

Group type: EXPERIMENTAL
Intervention: 100 mg oral sumatriptan
Number of subjects: 358

Group type: COMPARATOR
Intervention: 900 mg oral aspirin plus 10 mg oral metoclopramide
Number of subjects: 358
Study: 3933736

Group type: EXPERIMENTAL
Intervention: Sodium supplementation
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 31088418

Group type: EXPERIMENTAL
Intervention: Enhanced open-door policy with additional strategic and personnel support on intervention wards.
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control wards opened facultatively without the enhanced open-door policy.
Number of subjects: 2
Study: 30101600

Group type: EXPERIMENTAL
Intervention: Improved written materials (intervention group)
Number of subjects: 670
Study: 27090149

Group type: EXPERIMENTAL
Intervention: 8-week vocal music therapy treatment group
Number of subjects: 55

Group type: COMPARATOR
Intervention: waitlist control group
Number of subjects: 55
Study: 25099533

Group type: EXPERIMENTAL
Intervention: Minimal guided iSMI (GET.ON Stress)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Unguided iSMI (GET.ON Stress)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting list control condition (WLC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cost-effectiveness analysis from societal perspective
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cost-benefit analysis from employer's perspective
Number of subjects: 0
Study: 21081251

Group type: EXPERIMENTAL
Intervention: Sildenafil 20mg thrice daily in addition to bosentan
Number of subjects: 32
Study: 19348535

Group type: EXPERIMENTAL
Intervention: Positive affective priming using verbal primes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Positive affective priming using pictorial primes
Number of subjects: 0
Study: 17469728

Group type: EXPERIMENTAL
Intervention: Rectal artesunate 10 mg/kg/day for 3 days followed by oral mefloquine 25 mg/kg
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Rectal artesunate 20 mg/kg/day for 3 days followed by oral mefloquine 25 mg/kg
Number of subjects: 70
Study: 15207886

Group type: EXPERIMENTAL
Intervention: Rimostil (57.2 mg total isoflavones)
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Promensil (82 mg total isoflavones)
Number of subjects: 252

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Rimostil and Promensil
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 252
Study: 11699249

Group type: EXPERIMENTAL
Intervention: Gamma linolenic acid containing products
Number of subjects: 47

Group type: COMPARATOR
Intervention: Various herbal therapies
Number of subjects: 47
Study: 9828735

Group type: EXPERIMENTAL
Intervention: Oral vancomycin (15 mg/kg every 8 hours for 7 days)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo solution
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Necrotising enterocolitis (in both groups)
Number of subjects: 140
Study: 1693088

Group type: EXPERIMENTAL
Intervention: Method WGS (spoken instructions included)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Method WGSD (spoken instructions and video demonstration included)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Method WG (graphics included)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Method W (written instructions only)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Method WGSD (video demonstration included)
Number of subjects: 20
Study: 387491

Group type: EXPERIMENTAL
Intervention: Finorgal
Number of subjects: 30

Group type: COMPARATOR
Intervention: Nitrazepam
Number of subjects: 30

Group type: COMPARATOR
Intervention: Triclofos sodium
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Finorgal, Nitrazepam, Triclofos sodium
Number of subjects: 30
Study: 29997167

Group type: EXPERIMENTAL
Intervention: Hypothermia (intensive care with cooling of the body to 33.5°C for 72 hours)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control (intensive care alone)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Hypothermia
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control
Number of subjects: 130
Study: 27858219

Group type: EXPERIMENTAL
Intervention: Depression (measured by Patient Health Questionnaire and Mental Health Index of the SF-36)
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Catastrophizing (measured by Coping Strategies Questionnaire)
Number of subjects: 241
Study: 24947595

Group type: EXPERIMENTAL
Intervention: Active tDCS (1 mA anodal stimulation to the left dorsolateral prefrontal cortex for 20 minutes on 10 consecutive days)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 26

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 26
Study: 22752876

Group type: EXPERIMENTAL
Intervention: Grape seed extract (GSE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 21116598

Group type: EXPERIMENTAL
Intervention: Polyethylene glycol 4000 without electrolytes
Number of subjects: 38

Group type: COMPARATOR
Intervention: Magnesium hydroxide
Number of subjects: 38
Study: 19459773

Group type: EXPERIMENTAL
Intervention: 0.2 ppm ozone for 2 h
Number of subjects: 15
Study: 16764869

Group type: EXPERIMENTAL
Intervention: Oral contraceptives initiated at 10 mm follicle diameter
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Oral contraceptives initiated at 14 mm follicle diameter
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Oral contraceptives initiated at 18 mm follicle diameter
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 45
Study: 15526045

Group type: EXPERIMENTAL
Intervention: Nevirapine (NVP)
Number of subjects: 706

Group type: COMPARATOR
Intervention: Efavirenz (EFV)
Number of subjects: 706
Study: 11724652

Group type: EXPERIMENTAL
Intervention: Ultrasonically nebulized distilled water (UNDW) 8 ml
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ultrasonically nebulized distilled water (UNDW) 16 ml
Number of subjects: 10

Group type: COMPARATOR
Intervention: Isotonic solution
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: N(G)-nitro-L-arginine methyl ester (L-NAME)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ultrasonically nebulized distilled water (UNDW) after L-NAME
Number of subjects: 10
Study: 9129015

Group type: EXPERIMENTAL
Intervention: Tumor-specific idiotype vaccine (tumor Ig protein coupled to keyhole limpet hemocyanin and emulsified in an immunologic adjuvant)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Tumor-specific idiotype vaccine
Number of subjects: 41
Study: 7895178

Group type: EXPERIMENTAL
Intervention: Synthetic human parathyroid hormone (PTH 1-38) infusion for 24 hours in 14 healthy females
Number of subjects: 36

Group type: COMPARATOR
Intervention: Primary hyperparathyroidism (HPT)
Number of subjects: 36
Study: 3249838

Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Zopiclone
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo for Diazepam
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo for Zopiclone
Number of subjects: 32
Study: 31237948

Group type: EXPERIMENTAL
Intervention: Antibiotic exposure (from 14 days before to 7 days after vaccination)
Number of subjects: 1174

Group type: COMPARATOR
Intervention: Nonexposed to antibiotics
Number of subjects: 1174
Study: 29633247

Group type: EXPERIMENTAL
Intervention: Benzene exposure during childhood above the 90th percentile
Number of subjects: 1989

Group type: EXPERIMENTAL
Intervention: Higher benzene exposure
Number of subjects: 1989
Study: 28739134

Group type: EXPERIMENTAL
Intervention: Dextromethorphan (DXM) 0.8 mg/kg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: MAST (stress-induction)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 26697137

Group type: EXPERIMENTAL
Intervention: n‐3 long chain polyunsaturated fatty acids (n‐3 LC‐PUFA) enriched enteral formula (98 mg/d eicosapentaenoic acid and 46 mg/d docosahexaenoic acid)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: n‐3 long chain polyunsaturated fatty acids (n‐3 LC‐PUFA) enriched enteral formula
Number of subjects: 55

Group type: COMPARATOR
Intervention: Reference enteral diet
Number of subjects: 55
Study: 22652346

Group type: EXPERIMENTAL
Intervention: Brief psycho-education intervention about cognition
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 80
Study: 20801941

Group type: EXPERIMENTAL
Intervention: Olmesartan medoxomil (OM) 20 mg/day for 3 weeks, uptitrated to OM 40 mg/day, OM/HCTZ 40/12.5 mg/day, and OM/HCTZ 40/25 mg/day
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Olmesartan medoxomil (OM) ± hydrochlorothiazide (HCTZ)
Number of subjects: 192
Study: 19066678

Group type: EXPERIMENTAL
Intervention: Oxazepam
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Naproxen
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Zopiclone
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Oxycodone
Number of subjects: 60
Study: 15845566

Group type: EXPERIMENTAL
Intervention: Gemcitabine 1000 mg/m(2) on days 1 and 8 plus docetaxel 50 mg/m(2) on day 8
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Recommended regimen (Gemcitabine 1000 mg/m(2) on days 1 and 8 plus docetaxel 50 mg/m(2) on day 8)
Number of subjects: 59
Study: 12875145

Group type: EXPERIMENTAL
Intervention: Participation in Heart School activities (intervention group)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Declined participation in Heart School activities (comparison group)
Number of subjects: 184
Study: 10609423

Group type: EXPERIMENTAL
Intervention: Family-focused psychoeducational therapy (FFT)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Crisis management with naturalistic follow-up (CMNF)
Number of subjects: 22